Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNYNF) Payables (2016 - 2025)

Historic Payables for Sanofi (SNYNF) over the last 17 years, with Q4 2025 value amounting to $8.6 billion.

  • Sanofi's Payables rose 620.08% to $8.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $8.6 billion, marking a year-over-year increase of 620.08%. This contributed to the annual value of $8.3 billion for FY2025, which is 178.58% up from last year.
  • Latest data reveals that Sanofi reported Payables of $8.6 billion as of Q4 2025, which was up 620.08% from $8.0 billion recorded in Q2 2025.
  • In the past 5 years, Sanofi's Payables registered a high of $8.6 billion during Q4 2025, and its lowest value of $6.5 billion during Q2 2021.
  • Its 5-year average for Payables is $7.6 billion, with a median of $7.9 billion in 2023.
  • As far as peak fluctuations go, Sanofi's Payables surged by 1942.31% in 2021, and later crashed by 168.04% in 2022.
  • Quarter analysis of 5 years shows Sanofi's Payables stood at $7.1 billion in 2021, then decreased by 1.68% to $7.0 billion in 2022, then increased by 13.43% to $7.9 billion in 2023, then rose by 2.34% to $8.1 billion in 2024, then increased by 6.2% to $8.6 billion in 2025.
  • Its last three reported values are $8.6 billion in Q4 2025, $8.0 billion for Q2 2025, and $8.1 billion during Q4 2024.